Trends in the treatment of cytomegalovirus infection in oncohematological patients
Cytomegalovirus (CMV)-related complications remain an extremely serious and urgent problem in immunocompromised patients. Ganciclovir (GCV) is efficient for the treatment of CMV-infection, but myelotoxicity limits the possibilities of their application. In addition, prolonged or intermittent courses...
Saved in:
Main Author: | D. N. Balashov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/43 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Hearing Phenotypes Among Children With Congenital Cytomegalovirus and Other Non‐Cytomegalovirus Conditions
by: Shi Liang, et al.
Published: (2025-04-01) -
Evaluation of the effectiveness of prophylactic strategies for cytomegalovirus infection in pediatric kidney recipients
by: O. M. Tsirulnikova, et al.
Published: (2022-01-01) -
Cytomegalovirus genetic diversity
by: O. E. Vankova, et al.
Published: (2017-06-01) -
Clinical Characteristics of Cytomegalovirus Disease of the Upper Gastrointestinal Tract: A 10-Year Multicenter Retrospective Study
by: Ga-Ram You, et al.
Published: (2023-12-01) -
Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions
by: A. A. Dmitrova, et al.
Published: (2022-06-01)